Lisa Egbuonu-Davis, MD, has broad strategic and operational experience in pharmaceuticals, public health, and consulting, including expertise in developing and implementing research commercialization and investment strategies for a variety of patient populations.

Dr. Egbuonu-Davis has served on the boards of Omega Healthcare Inc. (NYSE: OHI), a real estate investment firm focused on skilled nursing facilities (since 2021); Avanos Medical Inc. (NYSE: AVNS), a medical technology company with products for pain management and digestive health (since 2023); and Phreesia (NYSE: PHR), a software company for patient intake, payment processing, and patient activation (since 2023).

From 2019 to 2023, Dr. Egbuonu-Davis served as vice president, medical innovations, for DH Diagnostics LLC, an affiliate of Danaher Corp. (NYSE: DHR), where she provided medical advice to influence research, partnership, and investment strategy across Danaher’s diagnostic platform businesses. During this period, she also served at various times as interim chief medical officer for certain subsidiaries of Danaher Corp.

From 2015 to 2019, she served as vice president, global patient centered outcomes and solutions at Sanofi Inc. (Nasdaq: SNY). At Sanofi, Dr. Egbuonu-Davis created patient programs, services, and tools to enhance adherence and health outcomes in patients with chronic conditions. Prior to Sanofi, Dr. Egbuonu-Davis had cofounded and served as director for ROI Squared LLC, a privately held life science company focused on diagnostic medical devices. She also served as managing director for LED Enterprise LLC, where she advised biopharmaceutical companies and trade associations on health-care reform, technology assessment, quality metrics, and incentives and implications for research and services. Additionally, she served in senior advisor roles for Avalere Health and Booz Allen Hamilton. Prior to that, she served for 13 years in various roles at Pfizer Inc. (NYSE: PFE), where she led clinical and outcomes research departments, supported product value assessments in support of reimbursement and adoption, and influenced product investment and development decisions.

Dr. Egbuonu-Davis currently serves on the Johns Hopkins Medicine Board of Trustees and the National Advisory Council for the Johns Hopkins University School of Education.

She earned her master of business administration in healthcare management from the University of Pennsylvania’s Wharton School. She holds doctor of medicine and master of public health (epidemiology) degrees from Johns Hopkins University. She is board certified in pediatrics.